blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3555627

EP3555627 - FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.09.2024
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  20.10.2023
FormerGrant of patent is intended
Status updated on  04.06.2023
FormerExamination is in progress
Status updated on  01.04.2022
FormerRequest for examination was made
Status updated on  20.09.2019
FormerThe international publication has been made
Status updated on  23.06.2018
Most recent event   Tooltip27.09.2024No opposition filed within time limitpublished on 30.10.2024 [2024/44]
Applicant(s)For all designated states
Purdue Research Foundation
101 Foundry Drive, Suite 2500
West Lafayette, IN 47906 / US
[2023/45]
Former [2019/43]For all designated states
Purdue Research Foundation
1801 Newman Road
West Lafayette, IN 47906-4182 / US
Inventor(s)01 / LOW, Philip Stewart
1801 Newman Road
West Lafayette, Indiana 47906 / US
02 / ROY, Jyoti
1801 Newman Road
West Lafayette, Indiana 47906 / US
 [2019/43]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[2019/43]
Application number, filing date17880889.513.12.2017
[2019/43]
WO2017US65995
Priority number, dateUS201662434380P14.12.2016         Original published format: US 201662434380 P
US201762575050P20.10.2017         Original published format: US 201762575050 P
[2019/43]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018111989
Date:21.06.2018
Language:EN
[2018/25]
Type: A1 Application with search report 
No.:EP3555627
Date:23.10.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 21.06.2018 takes the place of the publication of the European patent application.
[2019/43]
Type: B1 Patent specification 
No.:EP3555627
Date:22.11.2023
Language:EN
[2023/47]
Search report(s)International search report - published on:US21.06.2018
(Supplementary) European search report - dispatched on:EP16.07.2020
ClassificationIPC:G01N33/574, A61K49/00, A61K51/04, G01N33/58, A61K47/55, A61P35/00, A61P35/04, G01N33/569
[2020/34]
CPC:
G01N33/574 (EP); A61K47/545 (CN); A61K51/0497 (EP,US);
A61K45/00 (CN); A61K47/55 (EP,US); A61K47/65 (CN);
A61K49/0032 (EP,US); A61K49/0043 (EP,US); A61K49/0052 (EP,CN,US);
A61K49/0056 (CN); A61K49/04 (CN); A61P35/00 (EP,CN);
A61P35/04 (EP); G01N33/56966 (EP,US); G01N33/58 (EP) (-)
Former IPC [2019/43]G01N33/574, A61K49/00, A61K51/04, G01N33/58
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/43]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:AUF FIBROBLASTENAKTIVIERUNGSPROTEIN (FAP) GERICHTETE BILDGEBUNG UND THERAPIE[2019/43]
English:FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY[2019/43]
French:IMAGERIE ET THÉRAPIE CIBLÉES PAR UNE PROTÉINE D'ACTIVATION DES FIBROBLASTES (FAP)[2019/43]
Entry into regional phase12.07.2019National basic fee paid 
12.07.2019Search fee paid 
12.07.2019Designation fee(s) paid 
12.07.2019Examination fee paid 
Examination procedure12.07.2019Examination requested  [2019/43]
15.02.2021Amendment by applicant (claims and/or description)
31.03.2022Despatch of a communication from the examining division (Time limit: M06)
10.10.2022Reply to a communication from the examining division
05.06.2023Communication of intention to grant the patent
11.10.2023Fee for grant paid
11.10.2023Fee for publishing/printing paid
11.10.2023Receipt of the translation of the claim(s)
Opposition(s)23.08.2024No opposition filed within time limit [2024/44]
Fees paidRenewal fee
12.07.2019Renewal fee patent year 03
28.12.2020Renewal fee patent year 04
27.12.2021Renewal fee patent year 05
27.12.2022Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT22.11.2023
CZ22.11.2023
DK22.11.2023
EE22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
MC22.11.2023
PL22.11.2023
RO22.11.2023
RS22.11.2023
SK22.11.2023
SM22.11.2023
LU13.12.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
[2024/40]
Former [2024/36]AT22.11.2023
CZ22.11.2023
DK22.11.2023
EE22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
PL22.11.2023
RO22.11.2023
RS22.11.2023
SK22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/35]AT22.11.2023
CZ22.11.2023
DK22.11.2023
EE22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
PL22.11.2023
RO22.11.2023
RS22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/34]AT22.11.2023
DK22.11.2023
EE22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
PL22.11.2023
RS22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/33]AT22.11.2023
DK22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
PL22.11.2023
RS22.11.2023
SM22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/26]AT22.11.2023
HR22.11.2023
LT22.11.2023
LV22.11.2023
PL22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/25]AT22.11.2023
HR22.11.2023
LT22.11.2023
PL22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/24]AT22.11.2023
HR22.11.2023
LT22.11.2023
RS22.11.2023
BG22.02.2024
NO22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/23]AT22.11.2023
LT22.11.2023
BG22.02.2024
GR23.02.2024
IS22.03.2024
PT22.03.2024
Former [2024/21]LT22.11.2023
BG22.02.2024
GR23.02.2024
IS22.03.2024
Former [2024/20]GR23.02.2024
IS22.03.2024
Documents cited:Search[E]WO2019083990  (UNIV JOHNS HOPKINS [US]);
International search[A]US2003138432  (GLAZIER ARNOLD [US]);
 [A]US2011117025  (DACOSTA RALPH SEBASTIAN [CA], et al);
 [A]US2014099340  (JUNE CARL H [US], et al);
 [A]US2014271482  (LOW PHILIP S [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.